nafamostat has been researched along with Myocarditis in 2 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, she died of multiple organ failure and systemic cytomegalovirus infection in the chronic stage." | 1.32 | [Fulminant myocarditis treated with percutaneous cardiopulmonary support and long-term complications: three case reports]. ( Kusaba, T; Matsumuro, A; Nakahara, Y; Nakamura, T; Sawada, S, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kusaba, T | 1 |
| Nakahara, Y | 1 |
| Matsumuro, A | 1 |
| Nakamura, T | 1 |
| Sawada, S | 1 |
| Morishima, I | 1 |
| Sassa, H | 1 |
| Sone, T | 1 |
| Tsuboi, H | 1 |
| Kondo, J | 1 |
| Koyama, T | 1 |
2 other studies available for nafamostat and Myocarditis
| Article | Year |
|---|---|
[Fulminant myocarditis treated with percutaneous cardiopulmonary support and long-term complications: three case reports].
Topics: Acute Disease; Adolescent; Adult; Aged; Anticoagulants; Benzamidines; Cardiopulmonary Bypass; Fatal | 2004 |
A case of fulminant myocarditis rescued--by long-term percutaneous cardiopulmonary support.
Topics: Acute Disease; Adult; Antithrombins; Benzamidines; Complement Inactivator Proteins; Guanidines; Hear | 1994 |